-
The seemingly benign use of a checklist to ensure infection control measures are followed during a clinical procedure erupted in controversy recently when a federal agency questioned whether one such program fell into the category of human research.
-
-
Even as health care epidemiologists fear that "getting to zero" infection prevention efforts may be unleashing some unintended consequences, one highly successful program associated with the movement recently drew the praises of Congress.
-
The onus for much of the "needless suffering and death" caused by health care-acquired infections (HAIs) was recently ascribed to a failure of leadership by the Department of Health and Human Services (HHS) in a scathing report by the U.S. Government Accountability Office (GAO).
-
Once primarily a problem for large tertiary care hospitals, methicillin-resistant Staphylococcus aureus (MRSA) infections increasingly are a patient safety hazard in community settings.
-
The Joint Commission continues to emphasize the patient safety issue of medication administration, warning that children are at particular risk of harmful medication errors.
-
The Joint Commission has reiterated its standards require a clean hospital environment in light of comments and criticism at the Committee on Oversight and Government Reform's April 16th hearing on "Healthcare-Associated Infections (HAIs): A Preventable Epidemic."
-
In this Issue: Pioglitazone and heart disease; ARBs manufacturers spend
millions to show the non-inferiority of their products compared to less
expensive, generic ACE inhibitors; some athletes turn to growth hormone
because it is difficult to detect; FDA Actions
-
For 2 years beginning in February, 2005, every patient admitted to the Royal Infirmary of Edinburgh with community-acquired pneumonia (CAP) had blood levels of C-reactive protein (CRP) measured at the time of admission and (if still in the hospital) 4 days later. A standardized set of clinical and laboratory data was also acquired for each patient, per hospital routine.
-
Starting 4 months after publication of the ARDS Network's landmark study showing improved outcomes in patients with acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS) when low-tidal-volume, lung-protective ventilation (LPV) was used, investigators at the University of Pennsylvania prospectively identified 88 patients who met the accepted American-European Consensus Conference definition of ALI-ARDS.
